Adar Poonawalla

Premium

TMT

21 October, 2024

How Poonawalla booked a premium ticket to Karan Johar's firm despite sharp income skid

Pune-based tycoon and head of Covishield vaccine maker, Serum Institute of India, Adar Poonawalla signed an agreement Monday to pick ......

Premium

Healthcare

16 May, 2024

Exclusive: Poonawalla's Serum Institute forays into medtech via acquisition

Serum Institute of India (SII), the world's biggest vaccine maker, has picked up a minority stake in a medical technology company, two ......

Premium

Healthcare

24 July, 2023

Advent may rope in new investor for Bharat Serums with neat valuation markup

Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......

Healthcare

26 June, 2023

Zydus Life picks up stake in Mylab for $13 mn

Homegrown drug maker Zydus Lifesciences Limited has bought a stake in biotech company Mylab Discovery Solutions from Rising Sun Holdings, ......

Healthcare

25 April, 2023

Serum to double investment in PE-backed Biocon Biologics to $300 mn

A unit of Adar Poonawalla-led Serum Institute of India, the world's biggest vaccine maker, will double its investment to $300 ......

Premium

Finance

18 April, 2023

Magma HDI set for stake sale after failed PE deal with ICICI Venture, Morgan Stanley

Magma HDI General Insurance Co, which was a joint venture between Poonawalla FinCorp and German insurer HDI Global SE but ......

Premium

Finance

16 December, 2022

Will focus on core NBFC biz, looking at AUM growth of 35-40%: Adar Poonawalla

A day after the Poonawalla Group sold its housing finance arm Poonawalla Housing to private equity giant TPG for Rs ......

Finance

19 April, 2022

Poonawalla Fincorp enters consumer lending space

Poonawalla Fincorp Limited (formerly Magma Fincorp Limited) on Tuesday said it has forayed into the digital consumption loans space through ......

Premium

Finance

06 April, 2022

India Alternatives garners 5x returns on its first exit from second fund

The family office of Adar Poonawalla, who is the CEO of the world's largest manufacturer of vaccines by volume, Serum ......

TMT

21 December, 2021

Adar Poonawalla picks up 20% stake in JetSynthesys' video sharing arm Wakau

Serum Institute of India’s chief Adar Poonawalla has picked up a 20% stake in Wakau Interactive Pvt Ltd, a subsidiary ......